Department of Internal Medicine, Einstein Medical Center, Philadelphia, Pennsylvania, USA.
Division of Cardiology, Loma Linda University Health, Loma Linda, California, USA.
Cardiorenal Med. 2022;12(4):173-178. doi: 10.1159/000525730. Epub 2022 Jun 27.
Determination of adequacy of decongestion remains a significant challenge in the management of acute heart failure (AHF).
This is a prospective single center cohort study of patients (>18 years old) admitted for AHF on intravenous diuretics, with BNP >100 pg/mL or echocardiographic findings of reduced ejection fraction or diastolic dysfunction, and at least 1 clinical sign of volume overload. Patients with eGFR ≤45 mL/min or on dialysis, and with exposure to contrast dye or nephrotoxins were excluded. Serum and spot urine osmolality were obtained in the early morning simultaneously daily for 5 days or until discharge. Receiver operating characteristic curves were used to analyze the optimal cutoffs for the osmolality values in the prediction of heart failure (HF) readmissions Results: Of the total 100 patients, 62% were male and 59% were Black American. The mean age was 64.41 ± 12.53 and 34% had preserved ejection fraction. Patients with 30-day readmission had higher serum osmolality (mOsm/kg) on admission (305 [299-310] vs. 298 [294-303]; p = 0.044) and had higher drop in serum osmolality between admission and discharge (-7.5 [-9.0, -1.25] vs. -1.0 [-4.0, 4.0]; p = 0.044). Serum osmolality on admission of >299 mOsm/kg (sensitivity: 83%, specificity: 61%) and drop in serum osmolality between admission and discharge of >2 mOsm/kg (sensitivity: 83%, specificity: 65%) was associated with 30-day HF readmissions. No patients discharged with urine osmolality more than 500 mOsm/kg had 30-day readmissions, but this was not statistically significant, p = 0.334.
Measurement of serum osmolality and urine osmolality may have some utility in AHF, but interpretation should consider baseline values and dynamic changes to account for individual differences in sodium and water handling.
在急性心力衰竭(AHF)的治疗中,确定是否充分利尿仍然是一个重大挑战。
这是一项前瞻性单中心队列研究,纳入了因静脉利尿剂治疗而入院的 AHF 患者(年龄>18 岁),BNP>100pg/ml 或超声心动图提示射血分数降低或舒张功能障碍,且至少有 1 项容量超负荷的临床体征。排除 eGFR≤45ml/min 或正在透析、使用造影剂或肾毒性药物的患者。每天清晨同时采集血清和即时尿液渗透压,连续采集 5 天或直至出院。采用受试者工作特征曲线分析渗透压值对心力衰竭(HF)再入院的预测价值的最佳截断值。
总共 100 例患者中,62%为男性,59%为美国黑人。平均年龄为 64.41±12.53 岁,34%的患者射血分数正常。30 天再入院患者入院时血清渗透压(mOsm/kg)较高(305[299-310]vs.298[294-303];p=0.044),入院至出院期间血清渗透压下降幅度较大(-7.5[-9.0,-1.25]vs.-1.0[-4.0,4.0];p=0.044)。入院时血清渗透压>299mOsm/kg(灵敏度:83%,特异性:61%)和入院至出院期间血清渗透压下降幅度>2mOsm/kg(灵敏度:83%,特异性:65%)与 30 天 HF 再入院相关。没有患者出院时尿液渗透压>500mOsm/kg,但这在统计学上没有显著意义,p=0.334。
血清渗透压和尿液渗透压的测量可能在 AHF 中有一定的作用,但解释时应考虑基础值和动态变化,以考虑钠和水处理的个体差异。